Bcl-6 and bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: Correlation with 3q27 and 18q21 chromosomal abnormalities

Human Pathology

Volumn 30, Issue 7, 1999, Pages 803-808

  Skinnider, Brian F ^a   Horsman, Douglas E ^a   Dupuis, Beverley ^a   Gascoyne, Randy D ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Bcl 2; Bcl 6; Chromosome 18; Chromosome 3; Lymphoma

Indexed keywords

PROTEIN BCL 2;

ARTICLE; B CELL LYMPHOMA; CHROMOSOME 18Q; CHROMOSOME 3Q; CORRELATION FUNCTION; FOLLICULAR LYMPHOMA; GENE EXPRESSION REGULATION; GERMINAL CENTER; HUMAN; HUMAN TISSUE; PROTEIN EXPRESSION;

EID: 0032808894     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90141-7     Document Type: Article

References (37)

1. Chang C-C, Ye BH, Chaganti RSK, et al: BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc Natl Acad Sci U S A 93:6947-6952, 1996
2. Ye BH, Cattoretti G, Shen Q, et al: The BCL-6proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nature Genet 16:161-170, 1997
3. Dent AL, Shaffer AL, Yu X, et al: Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276:589-592, 1997
4. Bastard C, Deweindt C, Kerckaert JP, et al: LAZ3 rearrangements in non-Hodgkin's lymphoma: Correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood 83:2423-2427, 1994
5. Horsman DE, McNeil BK, Anderson M, et al: Frequent association of t(3;14) or variant with other lymphoma-specific translocations. Br J Hematol 89:569-575, 1995
6. Pescarmona E, Lo Coco F, Pacchiarotti A, et al: Analysis of the BCL-6 gene configuration in diffuse B-cell non-Hodgkin's lymphomas and Hodgkin's disease. J Pathol 177:21-25, 1995
7. Lo Coco F, Ye BH, Lista F, et al: Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood 83:1757-1759, 1994
8. Otsuki T, Yano T, Clark HM, et al: Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas: Results of rearrangement and gene expression studies and a mutational analysis of coding region sequences. Blood 85:2877-2884, 1995
9. Migliazza A, Martinotti S, Chen W, et al: Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma. Proc Nat Acad Sci U S A 92:12520-12524, 1995
10. Shen HM, Peters A, Baron B, et al: Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280:1750-1752, 1998
11. Pittaluga S, Ayoubi TAY, Wlodarska I, et al: BCL-6 expression in reactive lymphoid tissue and in B-cell non-Hodgkin's lymphomas. J Pathol 179:145-150, 1996
12. Onizuka T, Moriyama M, Yamochi T, et al: BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. Blood 86:28-37, 1995
13. Flenghi L, Bigerna B, Fizzotti M, et al: Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region. Am J Pathol 148:1543-1555, 1996
14. Cattoretti G, Chang C-C, Cechova K, et al: BCL-6 protein is expressed in germinal-center B cells. Blood 86:45-53, 1995
15. Omonishi K, Yoshino T, Sakuma I, et al: Bcl-6 protein is identified in high-grade but not low-grade mucosa-associated lymphoid tissue lymphomas of the stomach. Mod Pathol 11:181-185, 1998
16. Hockenbery D, Nunez G, Milliman C, et al: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336, 1991
17. Kondo E, Nakamura S, Onoue H, et al: Detection of bcl-2 protein and bcl-2 messenger RNA in normal and neoplastic lymphoid tissues by immunohistochemistry and in situ hybridization. Blood 80:2044-2051, 1992
18. Pezzella F, Tse AG, Cordell JL, et al: Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 137:225-232, 1990
19. Gascoyne RD, Adomat SA, Krajewski S, et al: Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood 90:244-251, 1997
20. Hill ME, MacLennan KA, Cunningham DC, et al: Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: A British National Lymphoma Investigation Study. Blood 88:1046-1051, 1996
21. Hermine O, Haioun C, Lepage E, et al: Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Blood 87:265-272, 1996
22. Allman D, Jain A, Dent A, et al: BCL-6 expression during B-cell activation. Blood 87:5257-5268, 1996
23. Korsmeyer SJ: Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80:879-886, 1992
24. Skinnider BF, Dupuis B, Gascoyne RD: The relationship between Bcl-2 and Bcl-6 protein expression in diffuse large B-cell lymphoma (DLCL). Mod Pathol 11:140A, 1998 (abstr)
25. Carbone A, Gaidano G, Gloghini A, et al: BCL-6 protein expression in AIDS-related non-Hodgkin's lymphomas: Inverse relationship with Epstein-Barr virus-encoded latent membrane protein-1 expression. Am J Pathol 150:155-165, 1997
26. Larocca LM, Capello D, Rinelli A, et al: The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells. Blood 92:1011-1019, 1998
27. Villuendas R, Piris MA, Orradre JL, et al: Different bcl-2 protein expression in high-grade B-cell lymphomas derived from lymph node or mucosa-associated lymphoid tissue. Am J Pathol 139:989-993, 1991
28. Monni O, Joensuu H, Franssila K, et al: BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. Blood 90:1168-1174, 1997
29. Liu YJ, Mason DY, Johnson GD, et al: Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol 21:1905-1910, 1991
30. Cattoretti G, Zhang J, Cleary AM, et al: Downregulation of BCL-6 gene expression by CD40 and EBV latent membrane protein-1 (LMP-1) and its block in lymphoma carrying BCL-6 rearrangements. Blood 90:175A, 1997 (abstr)
31. Offit K, Lo Coco F, Louie DC, et al: Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med 331:74-80, 1994
32. Offit K, Louie DC, Parsa NZ, et al: BCL6 gene rearrangement and other cytogenetic abnormalities in diffuse large cell lymphoma. Leukemia and Lymphoma 20:85-89, 1995
33. Liang R, Chan WP, Kwong YL, et al: High incidence of BCL-6 gene rearrangement in diffuse large B-cell lymphoma of primary gastric origin. Cancer Genet Cytogenet 97:114-118, 1997
34. Pescarmona E, de Sanctis V, Pistilli A, et al: Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomas. J Pathol 183:281-286, 1997
35. Engelhard M, Brittinger G, Huhn D, et al: Subclassification of diffuse large B-cell lymphomas according to the Kiel Classification: Distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor. Blood 89:2291-2297, 1997
36. Kwak LW, Wilson M, Weiss LM, et al: Clinical significance of morphologic subdivision in diffuse large cell lymphoma. Cancer 68:1988-1993, 1991
37. Warnke RA, Strauchen JA, Burke JS, et al: Morphologic types of diffuse large-cell lymphoma. Cancer 50:690-695, 1982